000 | 01348aam a22004331i 4500 | ||
---|---|---|---|
001 | 019967164 | ||
003 | Uk | ||
005 | 20240710103612.0 | ||
006 | m || d | | ||
007 | cr ||||||||||| | ||
008 | 200930s2018 |||||||fo |||| ||eng | ||
015 |
_aGBC0F8252 _2bnb |
||
020 |
_a9781496375155 _qEPUB |
||
020 |
_a1496375157 _qEPUB |
||
020 |
_a9781496375148 _qpbk |
||
040 | _aUk | ||
042 | _aukblsr | ||
072 | 7 |
_aMED _x062000 _2bisacsh |
|
082 | 0 | 4 | _a616.99/4061 |
130 | 0 | _aCancer chemotherapy and biotherapy. | |
245 | 1 | 0 |
_aCancer chemotherapy, immunotherapy, and biotherapy : _bprinciples and practice _h[E-Book] |
250 | _a6th ed. | ||
264 | 1 |
_a[Place of publication not identified] : _bWolters Kluwer Health, _c2018. |
|
300 | _a1 online resource (640 pages). | ||
336 |
_atext _2rdacontent |
||
337 |
_acomputer _2rdamedia |
||
338 |
_aonline resource _2rdacarrier |
||
650 | 0 |
_aCancer _xChemotherapy. |
|
650 | 0 |
_aCancer _xImmunotherapy. |
|
650 | 0 | _aAntineoplastic agents. | |
650 | 0 | _aBiological response modifiers. | |
650 | 1 | 2 |
_aNeoplasms _xdrug therapy. |
650 | 2 | 2 |
_aAntineoplastic Agents _xtherapeutic use. |
650 | 2 | 2 |
_aBiological Products _xtherapeutic use. |
650 | 2 | 2 |
_aNeoplasms _xtherapy. |
700 | 1 |
_aChabner, Bruce, _eeditor. |
|
700 | 1 |
_aLongo, Dan L. _eeditor. |
|
942 | _n0 | ||
999 |
_c95679 _d95679 |